Conclusions-Most reactive pharmacy interventions concerned prescribing errors with a limited potential for medical harm, but a small number of detected errors with a major potential for medical harm; cost savings were not appreciable.
study of the effects of bereavement on physical and mental health.
Although the study was based on a single practice several recommendations can be made. Poor communication may be due to a variety of reasons, but one main cause can be attributed to the large number of _7 people who may be involved in the terminal care. Members of a multidisciplinary team must know each other's roles and must be able to develop strategies to allow them to work together. A second recommendation is to advise relatives about the services available and to encourage them to use them. 6 Practices could produce leaflets on the services and aids available locally. These leaflets could also list the other members of the primary health care team, explaining their roles and outlining how they could help patients and their relatives. Many charities already produce leaflets to help patients and relatives find help and enable them to cope with their illnesses and the common problems encountered.
Thirdly, there is a need for improvement in the organisation of bereavement counselling, particularly home visits initiated by the general practitioner. We recommend that general practitioners undertake bereavement counselling and that there is a well organised system for following up bereaved relatives.
Perhaps practices could keep diaries and systematically plan post-bereavement visiting in the following year. It is also important to record deaths in a relative's case notes. Many relatives present at the surgery around the anniversary of a loved one's death, and unless the doctor is aware ofthis the real reason for the consultation -for example, a depressive illness-can be missed.
Finally, as bereavement commonly causes an increase in both psychiatric and non-psychiatric symptoms it is important that general practitioners not only are aware of this fact but also that they know how to deal with it.
I thank the general practitioners and relatives of the deceased for participating in this study, and Mrs A Moss and Mrs H Smith for secretarial help. The pharmacists recorded relevant drug details, summarised and categorised the problem, and coded outcomes on a form (figure), and in addition recorded the total time taken to initiate and resolve the intervention and the grade of the prescribing doctor. The potential for medical harm was graded separately by a single doctor. The outcome(s) that the prescribing error could produce were identified and categorised according to the degree of harm that would have resulted if the outcome had actually occurred (table I). The prescribing error was then rated for potential medical impact with reference to the likelihood of the outcome occurring (table II) .
In some instances the pharmacist's intervention was inappropriate, either because of a failure to appreciate more sophisticated prescribing behaviour by the addition, there were seven instances when large doses of paracetamol or aspirin were coprescribed as plain and compound (co-proxamol and Benoral) or for regular use and as required, or both. One patient was prescribed co-proxamol two tablets four times daily, paracetamol 1 g four times daily, co-proxamol two tablets as required, and paracetamol 1 g as required.
Errors in administration arose in 39 instances, including use of an inappropriate preparation for parenteral administration and one incident when a contaminated syringe pump was identified. Six instances concerned administration of drugs (silver sulphadiazine (Flamazine), papaveretum, and tetracosactrin (Synacthen)) or infusions (dopamine, etomidate, and insulin) which had not been prescribed.
ACCEPTANCE OF PHARMACIST'S RECOMMENDATION
In 639 cases (83%) the pharmacist's intervention was accepted, resulting in an alteration of the prescription in 575 (75%); in 92 the prescription was unaltered or the information was not accepted; in eight the information was already known; and in five the pharmacist considered that the intervention was inappropriate; a further 25 interventions were considered inappropriate by the medical assessor. OUTCOME Overall, there was an appreciable improvement in the quality of the prescription in 246 cases or a minor improvement in 231. In 185 cases the intervention had no discernible effect, and in 107 its influence was unclear. Most interventions (427/646, 66%) had no effect on costs, 130 resulted in a saving of less than 50p, and in 39 there was a larger saving. Some interventions increased drug costs (by less than 50p in 46 cases and bv more in four).
TIME ASSOCIATED WITLI INTERVENTION
A record of the time taken to make and to resolve the intervention was available for 730 of the 769 interventions and comprised a total of 96 7 pharmacist hours, representing an average of 41 minutes per pharmacist per week. The average time to resolve each problem was 7 9 (SE 0 8) minutes. Those problems involving the correct choice of drug and its administration (choice of drug, dose, route, duration, consideration ofadverse effects, interactions, and administration) took significantly longer (9 1 (1 -8) minutes) than more bureaucratic interventions (illegible, illegal, or incomplete prescriptions and prescribing of non-formulary items), which took 6 4 (4 6) minutes (p<0 05).
Discussion
Much of the scrutiny of medical behaviour and prescribing that is currently performed is based on economic appraisal. The Insulin treatment must be continued in this patient. Frequent blood glucose monitoring is essential to identify hypoglycaemia or hyperglycaemia and urine analysis should be done to detect ketonuria and so indicate any need for additional insulin-for example, ketones "small," 2 extra units; ketones "moderate," 4 extra units; ketones "large," 6 units of short acting insulin. rhe patient should be encouraged to take his exchanges in a lighter form spread throughout the day: suitable substitutes for 10 g of carbohydrate are a glass of milk, a small scoop of ice cream, a natural yoghurt (one pot), or natural, unsweetened fruit juice (one wine glass). A liberal intake of sugar free fluids should be encouraged.
Symptomatic treatment should be given for gastroenteritis. If there is clinical evidence of dehydration or acidosis immediate hospital admission should be arranged to allow correction of metabolic instability. Diabetic ketoacidosis may have a high mortality in the elderly, and if domestic back up is poor early rather than late admission should be arranged. A short admission may well prevent decompensation.
Prevention is the best approach, and two excellent leaflets, Coping When You Are Ill and on Insulin and Coping When You Are Ill and on Tablets or Diet Alone, are available from the British Diabetic Association, 10 Queen Anne Street, London WIM OBD. Such leaflets should be given to all patients or relatives at diagnosis. -D W M PEARSON, consultant physician, Aberdeen
Is there any limit of the maintenance dose of sulphasalazine in patients with ulcerative colitis? What are the risks of long term toxicity for a patient who has been taking 8-9 g a day for fouryears to keep her symptoms suppressed?
There is no firm evidence on which to base answers to either of these questions. Khan et al, however, in a controlled trial comparing 1, 2, and 4 g of sulphasalazine as maintenance treatment over six months, showed that 4 g gave a better therapeutic response than 2 g daily. ' The difference was not great and the incidence of side effects with the higher dose was considerably increased compared with that seen with the 2 g dose. Therefore, although higher doses can be used, the incidence of side effects may be high and the therapeutic gain seems to fall exponentially as the dose is increased. So far as is known, there is no long term toxicity for a patient taking 8-9 g daily, but this has not been systematically studied. -D P JEWELL, consultant physician, Oxford
